1

Programme

DAY 1 – 16 October 2019 1530 hrs Registration

Inaugural Session

Welcome Remarks by Ms Shobana Kamineni

Chairperson, ASIA HEALTH 2019 & Past President CII and Executive Vice Chairperson Apollo Hospitals Enterprise Limited

Opening Remarks by Dr Naresh Trehan Chairman CII National Council on Healthcare & Chairman and Manging Director Medanta – The Medicity

Remarks by Mr Chandrajit Banerjee Director General Confederation of Indian Industry

Dr Or Vandine Secretary of State for Health Ministry of Health Kingdom of Cambodia

Keynote Inaugural Address by Dr Harsh Vardhan Hon’ble Minister of Health and Family Welfare

Report Release

• Releasing the Report on ‘India as a Health Tech Hub’

• Releasing the Executive Summary on ‘Ayushman 2.0 – Indian Health Insurance – Vision 2030’

2

Concluding Remarks by Ms Shobana Kamineni

Chairperson, ASIA HEALTH 2019 & Past President CII and Executive Vice Chairperson Apollo Hospitals Enterprise Limited

Disruptive Innovators Voice (DIVE) - Future of Healthcare

Navigating through Digital Health Blackholes -?

Mr Egbert Schilling Commercial Director Babylon Health, UK

Labs of the Future Mr Shravan Subramanyam Managing Director India & Neighbouring Markets Roche Diagnostics India Private Limited

Indian Healthcare Industry – Through the Looking Glass’ Mr Sanjay Ubale Director-Partnerships Bill and Melinda Gates Foundation (BMGF) In Conversation with Mr Dilip Cherian Co - Founder Perfect Relations Private Limited

1930 hrs Onwards Networking Dinner

3

DAY 2 – 17th October 2019 0830 hrs

Registration

Plenary Session 1: “Emerging Health Challenges & Priorities” Today we are experiencing a growing burden of NCDs, Burden of Communicable Diseases, Malnutrition and what could be done to overcome these.

• What are some of the challenges being faced by Asian Countries- Similarities/ Differences?

• What are some of the different ways in which countries are tackling these common concerns

• Exchange and Learning from Each other – what could be taken back to be replicated

• How do we devise models where the Private and Public Sector can work together to achieve stronger Public Health systems and improved Health outcomes?

Moderated by Dr Naresh Trehan Chairman CII National Council on Healthcare & Chairman and Managing Director Medanta – The Medicity

Panellists Mr Vishal Bali Executive Chairman Asia Healthcare Holdings Senior Advisor - TPG Growth

Mr Sanjay Ubale Director-Partnerships Bill and Melinda Gates Foundation (BMGF)

Dr Poonam Khetrapal Singh Regional Director- South East Asia World Health Organisation (WHO)

4

Address by Dr Or Vandine Secretary of State for Health Ministry of Health Kingdom of Cambodia

Keynote Address by Mr Ashwini Kumar Choubey Minister of State – Health and Family Welfare

Plenary Session 2: “India as a Major Player - Global Med-Tech Hub” India offers a unique and dynamic platform for nurturing medical device innovations to transform ideas into reality. Recognising the immense growth potential of medical device sector, the Government of India has identified the medical devices industry as a sunshine sector for the Make in India initiative. Current initiatives need to be backed with a focus on increasing medtech demand and utilization through setting up of more healthcare facilities across tiers. An increase in demand will lead to an increase in production, thereby energizing the sector into increased production output. A boost to the manufacturing environment will spill over to the ancillary industries, skilling institutes and testing centres as well. In such favourable environment, FDI will flow in and indigenous players will also become more competitive in both the domestic and global markets. The current policies are in the direction of ‘protectionism’ and this may not have the desired effect in the long run.

• In such a scenario, what are the further steps to be taken to converge thoughts and realise the full potential of MedTech sector?

• What are the required policy initiatives that can facilitate ease of doing business and boost domestic manufacturing?

• How can uptake be increased for the 100 per cent FDI on offer? In this session, we review the MedTech journey thus far and ideate on the steps needed to grow India into a Global MedTech hub, that innovates as well as manufactures medical technology for the world.

Chaired by

Mr Himanshu Baid Chairman- CII Medical Technology Division and Managing Director Poly Medicure Limited

5

Panellists Mr Padma Kumar Chairman and Managing Director Terumo Penpol

Mr Marut Setia Chief Marketing Officer GE Healthcare, South Asia

Mr Madan Krishnan Managing Director Medtronic South Asia

Address by Dr Renu Swarup Secretary Department of Biotechnology Ministry of Science and Technology

Address by Mr Amitabh Kant CEO NITI Aayog

6

Plenary Session 3: “Reengineering Life – Health Technology- AI/Telemedicine - How is Technology poised to change access & affordability of Care?” Re-engineering Life – AI & Telemedicine - will delve into how technology is impacting the way healthcare is delivered, the role and synergies between practicing physicians and technology – and how can such synergies transform human abilities for judgement and precision of care. This session will talk about ‘smart’ technologies, can India lead innovations that are low cost and scalable? What are some of the enablers and barriers and what does the future of healthcare look like? How will the Clinical Care relationship evolve with increased usage of digital care giving platforms?

• What are some of the new skill sets and preparations that will be needed to deliver care?

• Are Virtual Clinics truly the missing link in harnessing patient -provider alliance?

• How Can Technology and AI help in reaching the last mile?

Moderated by Mr Rajan Navani

Chairman, CII's India@75 Council and Vice Chairman & Managing Director, JetLine Group of Companies

AI in Healthcare

Dr Vidur Mahajan Associate Director and Head of R&D Mahajan Imaging

Digital therapeutics and the virtual therapeutic alliance

Dr Matthew Heller Chief Innovations Officer Alex Therapeutics, Sweden

The flat World of Global Medicine - Technologies that flatten the global provision and extend healthcare access and affordability

Mr Rani Shifron Founder Healthier Globe, Israel

Uberisation of Healthcare Dr David Boucher Chief Strategy Officer Bumrungrad Hospital, Thailand

7

Address by Professor K VijayRaghavan Principal Scientific Adviser Government of India

Address by Dr Jitendra Singh Minister of State, Ministry of Development of NER(IC); PMO Personnel, Public Grievances and Pensions; and Department of Atomic Energy and Department of Space

Networking Lunch

In Conversation - ‘Balancing the Mind, Body and Soul – Finding Inner Equilibrium’ Sister Shivani Moderated by Dr Anupam Sibal Group Medical Director Apollo Hospitals Enterprise Limited

8

Plenary Session 4:

“Converging Stakeholders - The Challenges and Opportunities in enabling improved patient care” The Healthcare Sector even as it is poised to grow rapidly in the years to come – the world over as well as in India, continues to challenge itself to overcome barriers related to Quality, Accessibility and Affordability of Care. At the same time, there are many diverse industries that are joining hands to offer newer and innovative health solutions aimed at ultimately improving patient care. This session will deliberate on the benefits of such convergence across adjacent industries – the pharmaceuticals, hospitals, medical device manufacturing companies, Health Insurance and Technology.

• What are some of the strengths of each of these sectors which can be leveraged to create novel health solutions and efficiencies of operations?

• Can such convergence create opportunities that improve accessibility and affordability of quality care?

• Convergence in Healthcare is not unheard of however, the uptake of this has been slow – the session will deliberate on what ‘convergence can entail – improved access to home care, emotional support, virtual health visits, nutrition, health coaching etc

Moderated by Mr Shishir Sinha

Senior Deputy Editor Hindu Business Line

Panellists Dr Naresh Trehan Chairman CII National Healthcare Council and Chairman and Managing Director Medanta – The Medicity

Dr Ashutosh Raghuvanshi CEO Fortis Healthcare Ltd

Mr GV Prasad Chairman – CII National Committee on Pharmaceuticals & Co- Chairman and Managing Director Dr Reddy’s Laboratories Limited

9

Dr Rana Mehta

Senior Partner and Healthcare Lead PricewaterhouseCoopers (PwC)

Mr Himanshu Baid Chairman- CII Medical Technology Division & Chairman and Managing Director Poly Medicure Limited

Plenary Session 5: “Promoting India as a Medical Value Travel Destination - The Value Proposition of Indian Ayurveda, Indian Healthcare and Holistic Treatment” At a time when global healthcare costs are sky-rocketing, the world is looking at India, where high quality healthcare at NABH facilities at highly competitive price as compare to other similar healthcare facility in the world are being provided. This makes India a great destination for healthcare both for modern as well as traditional medicine and therapy. India also provides unmatched heritage in traditional ancient treatments like Ayurveda which have proven their efficacy and widely accepted as alternative treatment procedures across many countries.

• How can India leverage this amazing potential to serve global citizens through a combination of modern & traditional system of medicine?

• Despite inherent comparative and competitive advantages as a nation, India has not succeeded in harnessing this market appropriately, while neighbouring countries have positioned themselves strongly. What are therefore some of the lessons that we can learn from Thailand?

Moderated by Dr Naresh Trehan

Chairman CII National Healthcare Council & Chairman and Managing Director Medanta – The Medicity

Panellists Dr Pratap Chauhan

Member – CII Governing Council of Ayurveda Group & Founder & Director Jiva Ayurveda

10

Mr Arjun Sharma Co Chairman - CII National Committee on Tourism & Hospitality & Managing Director Select Group

Mr Partha Dey Chief Operating Officer Artemis Hospitals

Sharing the Thailand Story Dr David Boucher Chief Strategy Officer Bumrungrad Hospital, Thailand

Keynote Address by

Vaidya Rajesh Kotecha Secretary Ministry of AYUSH Mr Shripad Yasso Naik Hon’ble Minister of State for AYUSH

Plenary Session 6: “Integrating Care Continuum -– Are Synergies between the government, private healthcare and industry possible towards delivering value based care?” With increased digitisation, technology penetration and big data generation, India too is moving towards ‘value based healthcare’ where delivery of healthcare and its impact will be based increasingly on standardized health outcomes in a patients’ lifetime. Such integration will require massive realignment with the diverse and multiple stakeholders.herefore this session will seek to learn from lessons that have worked in delivering integrated Care and deep dive into how this is likely to work for a large population base

Moderated by Dr Shubnum Singh

(Director-Medical Education Medical Research & Advisor - Healthcare Framework) Max Healthcare Institute Ltd Max Institute of Medical Excellence (MIME) Max Super Speciality Hospital

11

Panellists Dr Randeep Guleria Director All India Institute of Medical Sciences (AIIMS)

Dr John Danaher

Head, Clinical Solutions Elsevier, USA

Mr T K Udairam Chief Operating Officer Sheares Healthcare, Singapore

Dr Santosh Shetty Chief Executive Officer Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute

Dr Richard Chivaka Chief Executive Officer Spark Health, South Africa

Ms Christina Wadhwani

Healthcare Systems Director Novartis, Switzerland

Disruptive Innovators Voice (DIVE) - Future of Healthcare

The Future of Healthcare – fashioning reality and perception

Mr Piyush Pandey Chief Creative Officer – Worldwide Executive Chairman – India Ogilvy

Labs of the Future Mr Sidhant Jena Founder Jena Care

12

The Future of anti-microbial resistance diagnosis

Ms Praapti Jayaswal CEO and Co-Founder Aarogya AI

E-ICU – Opening access to Specialist Care for the Last mile’

Dr Sandeep Dewan Founding Director Health Training Asia

1845 Hrs Close of Day 1

13

Day 3: 18th October 2019 0930 hrs

Plenary Session 7: “Financing Healthcare - Proposing ‘Ayushman 2.0 - Future Forward’ Government’s Ayushman Bharat Scheme aims to cover 40% of the total population (underprivileged belonging to SECC). This population is that which belongs to the underprivileged socio-economic caste census (SECC). The private health insurance industry proposes AB 2.0, a scheme designed to provide coverage to those belonging to above poverty line (APL) as well as those who are underprivileged and do not belong to the Socio-Economic Caste Census (SECC). This would be designed along the lines of Ayushman Bharat. The novelty of such a product would depend on the fact that it would be designed keeping in mind the care quality and not the care set-up i.e. in case of traditional health insurance systems. OPD/IPD, length of days, type of treatment and other conditions are set to make claims eligible. In AB 2.0 the industry proposes a product that would focus on OPDs and tele-consultations which under normal circumstances would not be covered. Other inclusions are pre and post hospitalisation, in-patient for AYUSH. This session would discuss other characteristics of such a product that would make it a default cover.

Moderated by Mr Annasamy Vaidheesh

Chairman, CII National Committee on Health Insurance & Vice President, South Asia & Managing Director India, GSK

Panellists Dr Naresh Trehan Chairman CII National Healthcare Council & Chairman and Managing Director Medanta – The Medicity

Mr R Venkatesh Managing Director Temasek

Mr Prashant Kumar Director KKR India Advisors

14

Dr Vinod K Monga

Secretary General Indian Medical Association (IMA)

Address by Dr Indu Bhushan CEO Ayushman Bharat and National Health Authority (NHA)

Address by Mr Abdulla Ameen Hon’ble Health Minister Government of Maldives

Keynote Address by Mr Anurag Thakur Hon’ble Minister of State for Finance & Corporate Affairs

Plenary Session 8: “Together for Health: What would we do to make Ayushmaan 2.0 happen” The various stakeholders of Ayushman Bharat 2.0 is a product that proposes to cover all in-patient hospital admissions for medical management and out-patient doctor consultations with minimal standard exclusions in a standardized insurance product that would cater to the protection needs of majority of the population. Technology is going to play a very important role in electronic management and re-imbursement of claims.

Moderated by Ms Malti Jaswal

Senior Consultant World Bank

Panellists Mr Annasamy Vaidheesh Chairman, CII National Committee on Health Insurance & Vice President, South Asia & Managing Director India, GSK

15

Dr Nishant Jain

Programme Director Indo-German Social Security Programme [GIZ] Dr Madan Gopal Senior Consultant NITI Aayog

Mr Sameer Agarwal Chief Financial Officer Manipal Health Enterprises

Ms Shobana Kamineni Chairperson, ASIA HEALTH 2019 & Past President CII and Executive Vice Chairperson Apollo Hospitals Enterprise Limited

Mr Mayank Bathwal Managing Director and CEO Aditya Birla Capital

Ms Tajinder Mukherjee Co-Chairperson – CII National Committee on Health Insurance & Chairman & Managing Director National Insurance Company Limited

Mr D V S Ramesh General Manager (Health) Insurance Regulatory and Development Authority of India (IRDAI)

Networking Lunch

16

Plenary Session 9: “Leveraging Technology for the greater good: Taking Cues from National Digital Health Blueprint (NDHB)” Beyond doubt, the future of health technologies is an exciting time. Health technologies encompass all the devices, medicines, vaccines, procedures and systems designed to streamline healthcare operations, lower costs and enhance quality of care. The future holds the promise of advanced health technologies such as Internet of Things (IoT), Artificial Intelligence (AI), blockchain, Big Data, Voice search, Chatbots, Virtual Reality (VR) and many more. The applications of these futuristic technologies are immense. This session will attempt to excite the audience regarding the endless possibilities that futuristic health technologies open in the field of Healthcare. With these technologies Government and Healthcare industry can cut costs and improve quality. It can be an interface for disease prevention, improving outcomes and reducing medical errors. It can aid therapeutic innovation, discovery, development, and safety utilizing data from past trials as well as analyzing trends from current data. The session will focus on how these technologies can be utilized to the benefit of the on – going Ayushman Bharat – Pradhan Mantri Jan Aarogya Yojana (PM-JAY). What would be the role of various stakeholders as the MoHFW releases the National Digital Health Blueprint for holistic adoption of the digital technologies and plan ahead for a Digital India?

• What currently is the biggest disruptor within the healthcare sector preventing technology being leveraged in the various different sectors?

• How do you perceive the sector to converge with technology at the fore, with AI, Telemedicine and IoT simultaneously cooperating with each other to ensure effective and efficient outcomes?

• How can we extract the economies of scale present within the sector and allow for the seamless transition to a digitally backed sector.

Moderated by Mr Joy Chakraborty

Chief Operating Officer PD Hinduja Hospital

Panellists Mr Dileep Mangsuli Chief Technology Officer GE Healthcare

17

Dr Michael Joseph Business Development Manager Brunel University, United Kingdom

Dr Karanvir Singh Chief Medical Information Officer Apollo Hospitals Enterprise Limited

Mr Nandkishore Dhomne Chief Information Officer Manipal Hospitals

Mr Ajay Seth Senior Director R&D Philips Healthcare

Keynote Address by Dr Vinod Paul Member NITI AAYOG

18

Plenary Session 10: “Designing sustainable mechanisms for Holistic Health” The need of the hour is to shift from more Traditional primary care models that emphasise the “disease model” to which one seeks to find a cure for the ailment towards a proactive primary care model whose foundations are laid on promoting preventive and healthy lifestyle. Such a shift has stemmed from the rapid demographic changes, a growing ageing population and a rapidly transforming healthcare sector as a result of technological advances. In order to design and deliver a sustainable wellness mechanism, appropriate infrastructure that is community centric is required. With the fragmented nature of our healthcare infrastructure and the ecosystem the session will deliberate on components needed to develop/transform centres into holistic wellness models that are patient-centric. This session will look into current challenges related to promoting sustainable healthy lifestyles in the workforce and the community at large, could incentive mechanisms be developed that encourage the young and old to remain healthy? Infrastructure gaps that exist, and how we can build for the future where society will focus on a more preventive lifestyle.

• What are the perceived barriers preventing the population to move from the traditional “disease” model to a more holistic preventive lifestyle model.

• With an increase in demand to mainstream AYUSH products in India, does the existing infrastructure, human resources and socioeconomic conditions allow for a sustainable mechanism to provide a holistic environment?

• While creating a sustainable mechanism, how can we incorporate wellness spaces and allow for the use of sustainable resources of energy to fuel a holistic life style?

Moderated by

Ms Upasna Kamineni Vice Chairperson Apollo Foundation

Panellists Dr Nalini Saligram Founder & CEO Arogya World

Dr P M Varier Managing Director Arya Vaidya Sala

19

Dr Harish Hande Chairman SELCO India

Dr Gorav Gupta Owner Tulasi Healthcare and Rehabilitation centre

Dr Praveen Gedam Deputy CEO National Health Authority (NHA)

Address by Pramod Kumar Pathak Additional Secretary Ministry of AYUSH

Plenary Session 11 “Analysing and overcoming Med Tech Regulatory Challenges” A comprehensive, globally harmonized and predictable regulatory regime is imperative for the medtech sector in India to realise its full potential. Such a regime will boost confidence of investors to develop quality medical devices and facilitate the setting-up of infrastructure facilities, especially the development of ancillary industry. Incomplete coverage of the vast medical device spectrum and the presence of multiple regulators is currently a huge challenge and steps need to be taken to formulate regulations that help industry overcome these. This session will seek to review the current medical device regulatory scenario and deliberate on measures that can eliminate regulatory bottlenecks for all stake-holders including innovators, manufacturers, suppliers, consumers, buyers and regulators. The session will focus on measures that can be taken to provide an impetus to make in India, facilitate ease of doing business while ensuring availability of better medical devices for patient care and safety.

Moderated by Ms Teena Thacker

Assistant Editor Economic Times

Panellists Mr Pavan Choudhury Managing Director Vygon India Private Limited

20

Mr Ajay Pitre Managing Partner Pitre Business Ventures LLP

Mr Sanjay Bhutani Co Chairman - CII Medical Technology Division & Managing Director – India Bausch & Lomb Eyecare (I) Pvt. Ltd.

Dr VG Somani Drug Controller General of India (DCGI) The Central Drugs Standard Control Organisation (CDSCO)

Address by Mr Mandeep Bhandari Joint Secretary Ministry of Health & Family Welfare

Special Address by Dr Vinod Paul Member NITI Aayog

21

Plenary Session 12 ‘The Business of Healthcare – Balancing the fine lines of Trust’ Healthcare is unique – because it is business with a soul – it deals with human lives, the patient - doctor alliance is critical to providing care and yet Healthcare is also a business that generates employment, provides livelihood and is currently one of the fastest growing sectors. Therefore how does one manage the fine lines of trust and business? What transformations could help keep this balance? Healthcare needs leaders who can guide an industry in the midst of disruption—from shifting government regulations and technological innovations to business competition and patients demanding better care for less. These leaders also need to understand the unique requirements of the industry and the gravity of healthcare’s role in daily life. The dichotomy is consumers want to be healthy, but they don’t necessarily want the “product” that is healthcare. Therefore can our business-minded leaders who will flip the business model to the customer, giving consumers the healthcare they want by focusing on customer satisfaction rather than the healthcare product?

Panellists Ms Divya Maderna

Member Rajasthan Legislative Assembly

Mr Viren Shetty Executive Director and Group COO Narayana Health

Mr Pankaj Sahni Chief Executive Officer Medanta – The Medicity

Ms Ameera Shah Managing Director & CEO Metropolis Healthcare Limited

Dr Dharminder Nagar Managing Director Paras Healthcare

Ms Upasna Kamineni Vice Chairperson Apollo Foundation

22

Valedictory Session

1800 Hrs High Tea

Close of ASIA HEALTH 2019